Table 2.
Serum MMP9 levels in age, gender, risk factors and maximal aortic diameter
| Control | AAA | TAA | P # | P * | P † | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MMP9(ng/ml) | P | MMP9(ng/ml) | P | MMP9(ng/ml) | P | |||||||
| Total | 258.79 ± 133.00 | 333.45 ± 138.57 | 385.17 ± 109.23 | <0.001 | <0.001 | 0.015 | ||||||
| Age | <65y(60) | 200.78 ± 139.20 | <0.001 | <65y(47) | 299.44 ± 160.84 | 0.029 | <65y(52) | 378.63 ± 96.80 | 0.464 | 0.004 | <0.001 | 0.013 |
| ≥65y(52) | 325.73 ± 86.94 | ≥65y(58) | 361.01 ± 111.50 | ≥65y(27) | 397.77 ± 131.00 | 0.087 | 0.005 | 0.143 | ||||
| Gender | male(83) | 260.57 ± 135.13 | 0.812 | male(78) | 328.11 ± 144.39 | 0.505 | male(55) | 390.09 ± 110.19 | 0.548 | 0.008 | <0.001 | 0.017 |
| female(29) | 253.69 ± 128.88 | female(27) | 348.88 ± 121.38 | female(24) | 373.90 ± 108.47 | 0.004 | 0.001 | 0.462 | ||||
| Hypertension | Yes(46) | 291.13 ± 114.98 | 0.026 | Yes(64) | 362.45 ± 140.89 | 0.007 | Yes(53) | 405.44 ± 91.35 | 0.038 | 0.013 | <0.001 | 0.141 |
| No(66) | 236.25 ± 140.71 | No(41) | 288.17 ± 123.34 | No(26) | 343.87 ± 131.23 | 0.053 | 0.001 | 0.099 | ||||
| Diabetes | Yes(14) | 308.00 ± 110.55 | 0.11 | Yes(23) | 316.37 ± 153.51 | 0.506 | Yes(33) | 379.07 ± 124.77 | 0.677 | 0.997 | 0.177 | 0.301 |
| No(98) | 251.76 ± 134.93 | No(82) | 338.24 ± 134.72 | No(46) | 389.55 ± 97.79 | <0.001 | <0.001 | 0.043 | ||||
| Hyperlipidemia | Yes(26) | 273.10 ± 128.94 | 0.494 | Yes(23) | 359.34 ± 151.80 | 0.313 | Yes(16) | 402.51 ± 100.01 | 0.481 | 0.099 | 0.002 | 0.644 |
| No(86) | 253.56 ± 134.85 | No(82) | 326.19 ± 134.73 | No(63) | 380.77 ± 111.77 | 0.002 | <0.001 | 0.026 | ||||
| Max. aortic diameter | NA | – | – | <5.5(60) | 334.62 ± 131.26 | 0.923 | <5.5(55) | 371.19 ± 112.91 | 0.085 | – | – | 0.114 |
| NA | – | ≥5.5(45) | 331.89 ± 149.26 | ≥5.5(24) | 417.22 ± 94.82 | – | – | 0.005 | ||||
AAA abdominal aortic aneurysm, TAA thoracic aortic aneurysm
P#: AAA vs. Control, P*: TAA vs. Control, P†: TAA vs. AAA